<DOC>
	<DOCNO>NCT00493727</DOCNO>
	<brief_summary>The study look effect 30 day treatment 15 diabetic proteinuria N-acetylcysteine ( Mucomyst ) dose 1 gm twice day mouth . The primary outcome measure change oxidant stress measurable change serum level isoprostane , Glutathione peroxidase , aconitase Total oxidant stress . Secondary outcome measure change proteinuria kidney function measure spot urine pr/cr estimate GFR MDRD formula .</brief_summary>
	<brief_title>Use Mucomyst Ameliorate Oxidant Stress Diabetics With Proteinuria</brief_title>
	<detailed_description>Mucomyst ( Acetylcysteine ) amelioration diabetic nephropathy Hypothesis : Treatment Mucomyst several month reduce oxidant stress thereby reduce proteinuria progression renal failure patient diabetic nephropathy . Rationale : Mucomyst Acetylcysteine find beneficial ameliorate radio-contrast induce acute renal failure several different study ( ref 1 ) The beneficial effect Mucomyst likely due antioxidative property . Oxidative stress play major role diabetic complication especially diabetic nephropathy . In recent vitro study Acetylcysteine ameliorate deleterious effect albumin culture renal proximal tubular epithelial cell . Murine proximal tubular cell treat albumin ( 30 mg/ml medium ) various lengths time . The result show albumin could activate Stat1 Stat5 within 15 min proximal tubular cell . The activation STATs mediate mostly Jak2 require protein synthesis . In addition , activation Stat1 occur even neutralization IFN- . The activation STATs inhibit N-acetyl-L-cysteine , precursor glutathione reactive oxygen specie ( ROS ) scavenger , fluorescence-activated cell sorter analysis show upregulation intracellular ROS albumin overloading , suggest albumin per se could generate ROS proximal tubular cell . The activation STATs occur way ROS generating system , especially membrane-bound NADPH oxidase system . Reduced activity glutathione peroxidase catalase could also responsible accumulation intracellular ROS . Hence , ROS generate system , also ROS scavenge system may contribute induction ROS albumin . N-acetylcysteine also may attenuate course hepatorenal syndrome , renal vasoconstrictive response indeterminate nature develop advanced liver failure . This effect , show experimental setting [ 9 ] preliminary clinical report [ 10 ] , could imply good preservation liver function . However , direct renal protective mechanism may play role also , consider ubiquitous distribution acylases catalyze deacetylation NAC [ 11 ] . Indeed , recent study suggest NAC may increase intracellular glutathione ameliorate renal ischemia-reflow injury [ 12-14 ] , inferior vena cava-occlusion [ 15 ] kidney damage cis-platinum [ 16 ] , cyclosporine [ 17 ] , nephrotoxic insult [ 18 , 19 ] . NAC report recently prevent radiocontrast nephropathy high-risk patient [ 20 ] . These study , conduct clinical trial without preliminary experiment animal , underscore safety oral NAC administration . As state , mechanism NAC-related organ protection primarily attribute scavenge oxygen free radical , either directly , increase intracellular glutathione concentration [ 3 , 4 ] . Indeed , decrease malonaldehyde production indicate attenuation membrane damage oxygen-free radical [ 3 ] , protective mechanism may play role well [ 21 ] . Improved local microcirculation may major potential NAC-related organ-protective mechanism . NAC report augment papillary flow [ 22 ] find improve renal vasodilation response acetylcholine [ 15 ] . Thus , perhaps protective effect NAC attribute improved glomerular hemodynamics prevention hypoxic tubular damage via restoration alter renal microcirculation . NAC ameliorate renal vasoconstriction , effect seem mediate mechanism prostaglandin nitric oxide NAC safely use large group ESRD patient one year ( 600 mg bid mouth ) prospective randomize trial . The group treat NAC reduction composite cardiovascular endpoint ( 18 % vs 47 % ) ( Ref : Circulation2003,107 : 992 . Tepel et al ) Similarly RCt Alzheimer patient NAC treatment 6 month show benefit cognitive task treatment group . ( Ref : Neurology2001 , 23 : 57 : Adair et al ) Intravenous injection NAC prior dialysis increase dialysis clearance homocysteine improve endothelial function group ESRD patient ( Ref : Circulation 2003 , 109 : 369 ; Scholze et al ) NAC treatment also find potentiate effect antihypertensive effect ACE inhibitor hypertensive patient ( Blood pressure 2002 , 11:235 ; Barrios et al ) In another RCT age population , chronic treatment NAC see cause significant decrease plasma TNF-alpha improve muscle strength . ( Ref : J Mol MED 2003 ; 81 : 118 ; Hauer et al . ) Protocol : All patient diabetes proteinuria level eligible study . Patients dialysis know allergy Mucomyst exclude Patients get Mucomyst 1000 mg mouth twice day 30 day . Urine serum collect beginning , , 15 30 day start Mucomyst 30 day stop Mucomyst . Portions blood urine frozen mail special lab measure chemical determine level oxidative stress . The particular chemical test isoprostane urine isoprostane , aconitase , glutathione peroxidase total serum antioxidant stress blood . The special test do Dr. Valyathan 's lab . Locally test blood urine proteinuria kidney Fx . Data collection : Demographic information : Wt , BP every visit : Med list rechecked every visit : At every visit : Collection blood different measure oxidant stress : serum frozen send Dr. Vallyathan 's lab later . Blood renal function test Spot urine protein/cr ( quantitative proteinuria ) also measure isoprostane Outcome : The primary outcome reduction measure oxidant stress marker serum isoprostane , glutathione peroxidase , aconitase , total oxidant stress . Secondary outcome reduction proteinuria change kidney function treatment Mucomyst .</detailed_description>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Diabetic proteinuria Allergy mucomyst pt dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Oxidative stress</keyword>
	<keyword>N-acetylcysteine</keyword>
	<keyword>NAC</keyword>
	<keyword>Isoprostane</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Mucomyst</keyword>
	<keyword>albuminuria</keyword>
</DOC>